Cargando…

Large-scale in-silico identification of a tumor-specific antigen pool for targeted immunotherapy in triple-negative breast cancer

Since the advent of cetuximab, clinical cancer treatment has evolved from the standard, relatively nonspecific chemo- and radiotherapy with significant cytotoxic side effects towards immunotherapeutic approaches with selective, target-mechanism-based effects. Antibody therapies as the most successfu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, Jessica, Wentzensen, Nicolas, Brinker, Titus J., Grabe, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493464/
https://www.ncbi.nlm.nih.gov/pubmed/31069014
http://dx.doi.org/10.18632/oncotarget.26808

Ejemplares similares